6-51856089-GA-GAAA

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2

The NM_138694.4(PKHD1):​c.7734-21_7734-20dupTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,448,334 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00082 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 2 hom. )

Consequence

PKHD1
NM_138694.4 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.207

Publications

0 publications found
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
  • polycystic kidney disease 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • Caroli disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP6
Variant 6-51856089-G-GAA is Benign according to our data. Variant chr6-51856089-G-GAA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1050840.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKHD1NM_138694.4 linkc.7734-21_7734-20dupTT intron_variant Intron 48 of 66 ENST00000371117.8 NP_619639.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKHD1ENST00000371117.8 linkc.7734-20_7734-19insTT intron_variant Intron 48 of 66 1 NM_138694.4 ENSP00000360158.3
PKHD1ENST00000340994.4 linkc.7734-20_7734-19insTT intron_variant Intron 48 of 60 5 ENSP00000341097.4

Frequencies

GnomAD3 genomes
AF:
0.000830
AC:
126
AN:
151772
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000218
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000721
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00146
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.00104
AC:
257
AN:
246858
AF XY:
0.00113
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000680
Gnomad ASJ exome
AF:
0.00121
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000141
Gnomad NFE exome
AF:
0.00176
Gnomad OTH exome
AF:
0.00100
GnomAD4 exome
AF:
0.00121
AC:
1568
AN:
1296444
Hom.:
2
Cov.:
22
AF XY:
0.00124
AC XY:
808
AN XY:
654098
show subpopulations
African (AFR)
AF:
0.000203
AC:
6
AN:
29524
American (AMR)
AF:
0.000712
AC:
31
AN:
43564
Ashkenazi Jewish (ASJ)
AF:
0.00108
AC:
27
AN:
25056
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38122
South Asian (SAS)
AF:
0.000441
AC:
36
AN:
81590
European-Finnish (FIN)
AF:
0.000132
AC:
7
AN:
53142
Middle Eastern (MID)
AF:
0.00312
AC:
17
AN:
5454
European-Non Finnish (NFE)
AF:
0.00143
AC:
1384
AN:
965550
Other (OTH)
AF:
0.00110
AC:
60
AN:
54442
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000823
AC:
125
AN:
151890
Hom.:
0
Cov.:
33
AF XY:
0.000768
AC XY:
57
AN XY:
74226
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41454
American (AMR)
AF:
0.000720
AC:
11
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4816
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10488
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00146
AC:
99
AN:
67904
Other (OTH)
AF:
0.00190
AC:
4
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000584
Hom.:
0
Bravo
AF:
0.000914

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 21, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: PKHD1 c.7734-21_7734-20dupTT alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 4/4 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.001 in 246858 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in PKHD1 causing Polycystic Kidney And Hepatic Disease (0.001 vs 0.0071), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.7734-21_7734-20dupTT in individuals affected with Polycystic Kidney And Hepatic Disease and no experimental evidence demonstrating its impact on protein function have been reported. One locus specific database reports a likely benign outcome. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely benign. -

Autosomal recessive polycystic kidney disease Benign:1
Sep 11, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Polycystic kidney disease 4 Benign:1
Aug 19, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.21
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201176305; hg19: chr6-51720887; API